VIRIDIAN THERAPEUTICS INC (VRDN)

US92790C1045 - Common Stock

19.75  -1.07 (-5.14%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to VRDN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 41.44. This target is 109.81% above the current price.
VRDN was analyzed by 23 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about VRDN.
In the previous month the buy percentage consensus was at a similar level.
VRDN was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 19.7522.2241.8241.4464.05 - 12.51% 111.75% 109.81% 224.30%
Up and Down Grades
Date Firm Action Rating
2024-12-17 RBC Capital Maintains Outperform -> Outperform
2024-12-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-05 RBC Capital Reiterate Outperform -> Outperform
2024-11-25 TD Cowen Initiate Buy
2024-11-25 Needham Reiterate Buy -> Buy
2024-11-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-13 Needham Reiterate Buy -> Buy
2024-10-28 Needham Reiterate Buy -> Buy
2024-09-26 BTIG Maintains Buy -> Buy
2024-09-19 RBC Capital Reiterate Outperform -> Outperform
2024-09-13 RBC Capital Maintains Outperform -> Outperform
2024-09-12 Goldman Sachs Maintains Buy -> Buy
2024-09-11 Needham Maintains Buy -> Buy
2024-09-10 BTIG Maintains Buy -> Buy
2024-09-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-30 Needham Reiterate Buy -> Buy
2024-08-28 RBC Capital Reiterate Outperform -> Outperform
2024-08-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-12 Oppenheimer Reiterate Outperform -> Outperform
2024-07-29 Wedbush Reiterate Outperform -> Outperform
2024-07-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-11 Wolfe Research Initiate Outperform
2024-06-11 Needham Reiterate Buy -> Buy
2024-06-06 Goldman Sachs Initiate Buy
2024-05-09 Ladenburg Thalmann Downgrade Buy -> Neutral
2024-05-09 Needham Reiterate Buy -> Buy
2024-05-09 Oppenheimer Maintains Outperform -> Outperform
2024-05-09 B. Riley Securities Downgrade Buy -> Neutral
2024-05-09 HC Wainwright & Co. Maintains Buy -> Buy